Listed on GrantGunner. Last checked 15 Nov 2026.
About this grant
This program supports international joint clinical trials for pharmaceuticals and regenerative medical products targeting intractable and rare diseases. Feasibility studies (FS) are eligible for up to 200 million yen (subsidy rate 10/10), and international joint clinical trials are eligible for up to 3 billion yen (subsidy rate 1/2, maximum 1.5 billion yen). Applications will be accepted via e-Rad from March 30 to noon on May 29, Reiwa 8.
Who can apply
A researcher (Research and Development Principal Investigator) who is affiliated with a domestic research institution or equivalent, and who is responsible for formulating research and development implementation plans and summarizing results, with their primary research location.
More grants from Japan Agency for Medical Research and Development (AMED)